Free Trial

Spectral AI Q2 2024 Earnings Report

Spectral AI logo
$1.21 -0.02 (-1.63%)
As of 04/4/2025 04:00 PM Eastern

Spectral AI EPS Results

Actual EPS
-$0.16
Consensus EPS
-$0.14
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Spectral AI Revenue Results

Actual Revenue
$7.48 million
Expected Revenue
$6.00 million
Beat/Miss
Beat by +$1.48 million
YoY Revenue Growth
N/A

Spectral AI Announcement Details

Quarter
Q2 2024
Time
After Market Closes
Remove Ads

Spectral AI Earnings Headlines

Spectral AI's (MDAI) Buy Rating Reiterated at HC Wainwright
Spectral AI, Inc. (NASDAQ:MDAI) Short Interest Down 12.8% in March
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Spectral AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Spectral AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spectral AI and other key companies, straight to your email.

About Spectral AI

Spectral AI (NASDAQ:MDAI), an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

View Spectral AI Profile

More Earnings Resources from MarketBeat